McKesson (MCK) Awarded $2.61B U.S. Defense Contract
McKesson Corp. (NYSE: MCK) said to have been awarded a U.S. defense contract covering mail order pharmaceutical delivery. The maximum value of the award is $2.61 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly's (LLY) Duloxetine Lilly Receives Positive CHMP Opinion
- UPDATE: Microsoft (MSFT) co-Founder Allen Commits $100M to Fight Ebola
- Vitae Pharmaceuticals (VTAE) Gains After Reporting Positive Results in Phase 1 Alzheimer's Disease Study
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!